Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 1.3% |
 |
Gilead SciencesGILD |
58 1.8% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
How do employees feel about the future at IGM Biosciences?
The Business Outlook at IGM Biosciences is neutral, according to employees. The average rating, aggregated from the top review sites in the US, of 51 out of 100 is decent. The rating is down, compared to previous month.
Analyzing Business Outlook, how is IGM Biosciences performing compared to its industry peers?
Compared to its peers, IGM Biosciences ranks in the 51st percentile when it comes to Business Outlook.
Why is it important to track the business outlook at IGM Biosciences?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at IGM Biosciences.
